Bio-IT World 2016 – Reception with Dr. Howard Jacob – Aviva Lev-Ari, PhD, RN will attend | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« 2nd Annual Translational Gene Editing: Exploiting CRISPR/Cas9 for Building Tools for Drug Discovery & Development: June 16, 2016, Boston, MA

Nature-inspired precisely assembled nanotubes »

Bio-IT World 2016 – Reception with Dr. Howard Jacob – Aviva Lev-Ari, PhD, RN will attend

March 30, 2016 by 2012pharmaceutical

Bio-IT World 2016 – Reception with Dr. Howard Jacob – Aviva Lev-Ari, PhD, RN will attend

Reporter: Aviva Lev-Ari, PhD, RN

Series B, Volume 2:

Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS & BioInformatics, Simulations and the Genome Ontology

https://www.amazon.com/dp/B08385KF87

From: “Kilke John (Illumina BIOIT2016)” <kilke.john@illumina-bioit2016.com>

Date: Wednesday, March 30, 2016 at 6:31 AM

To: Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>

Subject: Bio-IT World 2016 – drinks reception with Dr. Howard Jacob

Dear Aviva,

Following our brief, previous meeting I am inviting you to an exclusive drinks reception on the second night of this year’s conference in Boston.

It brings together research scientists, life sciences engineers, technologists, operations and data specialists for an evening of peer-to-peer discussions.

The drinks reception will be attended by Dr. Howard Jacob – who was the first in the world to successfully use DNA sequencing to identify and treat an unknown disease and in doing so saved the patient’s life. Under the title of ‘Genomic medicine is a team sport’, Dr. Jacob will be talking about his views on the future of genomics.

Attached is a short invitation PDF including full location details, times, etc.

The drinks reception is open to only 25 people – by invitation only. Therefore, please RSVP me by email or phone to reserve your place.

I look forward to seeing you in Boston

With kind regards,

Kilke

Kilke John

Bio-IT World event coordinator for Illumina

e: kilke.john@illumina-bioit2016.com

t: +44 20 3100 3578

Wednesday, April 6th 2016 (day two of the Bio-IT World conference)

Time: 6:30 – 8.30PM

Dr. Howard Jacob

Jacob is leading a team that is finding ways to change peoples’ lives. In his research, Jacob verifies that specific DNA changes cause disease. And he wants to find a way to pinpoint those genetic conditions fast enough to benefit a patient.

Jacob combines his team’s research with work from other investigators, bringing genome sequencing, data analysis and basic research together to make a diagnosis possible.

“My role is to integrate the independent work of researchers and create space for them to not only do world class science individually, but also contribute to a larger team,” Jacob says. “It’s one part participant, one part coach, one part motivator.”

“Science is inherently slow and methodical, which is great. But not
if you’re trying to help a sick patient.”

About Dr. Howard Jacob

Jacob has over 240 scientific publications, securing $85M of grant funding from the National Institutes of Health.

Following his PhD at the University of Iowa in 1989 and his postdoctoral work at Harvard, Stanford and MIT, Jacob was the founding director of the Human and Molecular Genetics Center and a professor in the departments of physiology and pediatrics at the Medical College of Wisconsin for nearly 20 years.
He led a team that was the first in the world to successfully use DNA sequencing to identify and treat an unknown disease in a patient. That experience saved the patient’s life and changed Jacob’s too.

“I always believed genomics was going to improve medicine,” he says. “But it went from being a dream to being a passion. I’m frustrated that we’re not helping more people today, when I know we could be changing lives. The good news is that we are going to be changing lives, and changing medicine, through genomics.”

By invitation only

Hosted by Illumina, this exclusive drinks reception is limited to only 25 attendees. It is designed to encourage peer-to-peer discussions among life sciences engineers and research scientists, as well as operations managers, technologists and data specialists.

Discussions will explore how the team sport of genomic medicine is driven on by translational informatics, advances of clinical genomics and next-gen sequencing – and clinical research with a sole focus on saving lives.